Does timing matter on tocilizumab administration? Clinical, analytical and radiological outcomes in COVID-19
RM Diaz, MAA García, FJT Muñoz… - European Journal of …, 2022 - ejhp.bmj.com
Introduction While there are no pharmacological treatments with proven efficacy for
coronavirus disease 2019 (COVID-19), tocilizumab has emerged as a candidate therapy …
coronavirus disease 2019 (COVID-19), tocilizumab has emerged as a candidate therapy …
[HTML][HTML] A safe protocol to identify low-risk patients with COVID-19 pneumonia for outpatient management
FJ Teigell Muñoz, E García-Guijarro… - Internal and Emergency …, 2021 - Springer
Abstract The coronavirus disease 2019 (COVID-19) outbreak has made it necessary to
rationalize health-care resources, but there is little published data at this moment regarding …
rationalize health-care resources, but there is little published data at this moment regarding …
[HTML][HTML] Bordetella hinzii endocarditis, a clinical case not previously described
MM González, MPC Romano… - European Journal of …, 2019 - ncbi.nlm.nih.gov
Materials and methods A 79-year-old male patient, with a chronic aortic valve biological
prosthesis, presented to hospital because of fever. First examinations were normal …
prosthesis, presented to hospital because of fever. First examinations were normal …
[CITATION][C] A safe protocol to identify low risk patients with COVID-19 pneumonia for outpatient management (preprint)
FJ Teigell Muñoz, E García-Guijarro… - 2020